REQUEST A DEMO
Total
USD $0.00
Search more companies

Global Pharma & Logistic S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Global Pharma & Logistic S.A.S. Profile Updated: December 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Global Pharma & Logistic S.A.S is a pharmaceutical company that specializes in respiratory disease and provides pharmaceutical intermediaries, raw materials, and medicines. They also offer active ingredients for the veterinary and cosmetic pharmaceutical industry. Global Pharma & Logistic S.A.S claims to target a global network of clients and provides active materials to support or directly take care of symptoms from diverse skin afflictions.

Headquarters
Carrera 50 50 - 14 Piso 15
Medellin; Antioquia;

Contact Details: Purchase the Global Pharma & Logistic S.A.S. report to view the information.

Website: http://global-pharma.com.co

Basic Information
Total Employees:
Purchase the Global Pharma & Logistic S.A.S. report to view the information.
Registered Capital:
Purchase the Global Pharma & Logistic S.A.S. report to view the information.
Financial Auditors:
Purchase the Global Pharma & Logistic S.A.S. report to view the information.
Incorporation Date:
October 21, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Global Pharma & Logistic S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-3.25%
Total operating revenue
-7.39%
Operating Profit/Loss (EBIT)
-55.84%
EBITDA
-55.47%
Net Profit/Loss for the Period
-64.41%
Total Assets
17.09%
Total Equity
-10.61%
Operating Profit Margin (ROS)
-10.11%
Net Profit Margin
-3.39%
Return on Equity (ROE)
-17.73%
Debt/Equity
6.39%
Quick Ratio
-0.07%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?